Sensitivity, Specificity, and Low Cost: Keys for the Clinical Implementation of CTCs Detection
Speakers: María Jose Serrano, PhD, Hospital Universitario Virgen de las Nieves, and...
At Fluxion, we’re passionate about delivering cell-based solutions that facilitate the transformation of research discoveries into new ways to diagnose and treat patients. By characterizing molecular and cellular mechanisms of disease, Fluxion’s platforms help bridge the translational medicine gap, enabling rapid advances in disease research, drug discovery, and the development of diagnostic tests.
Based on Fluxion's patented microfluidics, the IsoFlux System combines the power of antibody-based magnetic bead separations with the precision of flow cytometry. The IsoFlux System's superior performance is proven daily in labs around the world, setting standards for CTC isolation efficiency, purity, and ease of use.
The IsoFlux System enriches intact rare cells from biological samples and prepares them for further analysis. It gives you immediate access to high-quality, viable cells in a high-density format, ready for use in the application of your choice.
Visit our library of application notes, webinars, live demos, posters and publications.
For additional support, customers can access our support site for operation technical guides, cell culture optimizations, software updates, pre-recorded training, and troubleshooting guides.
Speakers: María Jose Serrano, PhD, Hospital Universitario Virgen de las Nieves, and...
Speakers: Jeff Jensen, CEO, Fluxion Biosciences
About This Presentation
This...
Speakers: Mercedes Marín-Aguilera, PhD, Research Fellow, Institut d'Investigacions...